In PC, MECOM was shown to be a critical regulator that suppresses acinar cell death by permitting cellular dedifferentiation (Backx et al., 2021), but there are limited studies regarding the other seven genes in pancreatic cancer. This evidence concerns the gene MECOM and familial pancreatic carcinoma.